MYCB1 medical cannabis manufacturing company profile, with Ernesto Diringuer

MYCB1 medical cannabis manufacturing company profile, with Ernesto Diringuer

MYCB1 medical cannabis manufacturing company profile, with Ernesto Diringuer. We spoke with Ernesto Diringuer, Founder and CEO of pharmaceutical-grade cannabis manufacturing company MYCB1, based in The Netherlands and now launching its product portfolio in Germany. Ernesto outlined his company’s business making and selling GMP cannabis products to pharmacies for doctors to prescribe. He also outlines plans for future clinical trials of their products. Ernesto also explained some research presented as a poster at the conference that shows an enormous 100,000,000 currently unmet medical needs in the EU.

 

MYCB1 medical cannabis manufacturing company profile

Medical conditions listed by prevalence include:
Chronic pain: 59,441,000
Pain in arthritis: 36,803,050
Rheumatic diseases: 31,206,525
Therapy-resistant glaucoma: 24,519,420
ADHD: 15,308,303
Fibromyalgia: 13,002,710
Epilepsy: 2,972,040
Chemotherapy-induced nausea and vomiting: 1,107,600
Pain in cancer: 502,320
These are needs his company is making cannabis medicines to help treat.

IACM Conference on Cannabinoids in Medicine aims to advance knowledge on cannabis, cannabinoids, the endocannabinoid system, and related topics especially with regard to their therapeutic potential. It supports research into cannabis products and the endocannabinoid system, and promotion of exchange of information between researchers, health care practitioners, patients, and the public.